10th Circuit Reverses Judgment In Herceptin Underfill MDL; No Federal Preemption
DENVER — The 10th Circuit U.S. Court of Appeals on May 29 reversed summary judgment in the Herceptin cancer drug underfill multidistrict litigation, saying the MDL court erred in finding that...To view the full article, register now.
Already a subscriber? Click here to view full article